Indian pharmaceutical stocks faced a decline as a result of Donald Trump’s recent warning about imposing tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, impacting major companies such as Gland Pharma and Sun Pharma. Trump’s announcement emphasized the aim to encourage pharmaceutical firms to relocate their manufacturing operations to the United States by using tariffs, affecting India’s considerable exports of generic drugs to the US.